ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewed
AMPK agonism optimizes the in vivo persistence and anti-leukemia efficacy of chimeric antigen receptor T cells
Erica Lynne Braverman, Mengtao Qin, Elisabet Ampudia-Mesias…·Craig Byersdorfer
This study shows that activating AMPK during CAR T cell expansion improves their in vivo persistence and anti-leukemia efficacy without altering expansion protocols or genetic constructs.
4 citations